Barriers To Immunotherapy: Success For Uveal Melanoma With Liver Metastases

Barriers to Immunotherapy: Success for Uveal Melanoma with Liver Metastases

A Cure In Sight

Introduction to liver-directed therapy & Immunotherapy Treatments in Uveal Melanoma, Ioannis Karydis

Uveal Melanoma with Liver Metastases: Patient Experience, Treatment Challenges & Hope on the Horizon

TriSalus Life Sciences

Treating uveal melanoma liver metastases with isolated hepatic perfusion

Progress in Treatment of Metastatic Uveal Melanoma

Νοσοκομείο Υγεία

Ask the Expert - Liver Directed Therapies for Metastatic Uveal Melanoma

Isolated Hepatic Perfusion-Treatment: Liver Metastases Of Uveal Melanoma-Preview

JoVE (Journal of Visualized Experiments)

Liver Directed Interventional Radiology Options for Uveal Melanoma (US)

Liver Directed Therapies

Interventional Immunotherapy: Transforming the Treatment of Solid Tumors

TriSalus Life Sciences

Combination Immunotherapy for Advanced Uveal Melanoma

Eyes on a Cure Mini OM Summit: Spring Updates - Panel One

COM701 & nivolumab in patients with metastatic MSS-CRC & liver metastases

Major Advances in Uveal Melanoma - 2022 Program: Melanoma Video Library

GRACE - Global Resource for Advancing Cancer Education

Targeted Therapy in Melanoma - Richard D Carvajal MD

Treatment of Primary and Metastatic Uveal Melanoma by Dan Gombos, MD

What's New in UVEAL Melanoma?

Metastatic Melanoma: The Immunotherapy Approach

Webinar: The PERIO-02 Trial - Enabling Immunotherapy for Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma Foundation

First FDA Approval for Metastatic Uveal Melanoma: What it Means for the OM Community